MET and metabolic dysfunction-associated steatohepatitis: Further support for the protective effect of Nrf2 came from a recent study showing that Nrf2 overexpression suppressed the deleterious effect on NASH progression of the hepatocyte-specific c-Met KO (known to trigger NASH development in MCD-fed mice) [78,79].